Cited by 413Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsVasculitis and related conditions

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Galli, Monica, Luciani, Davide, Bertolini, Guido, Barbui, Tiziano·2003·Blood

DOI 10.1182/blood-2002-11-3334

Open this paper in CoChat — free account

Abstract

The association of antiphospholipid antibodies with thrombosis and obstetric events defines the antiphospholipid syndrome. A recent systematic review of the literature showed lupus anticoagulants to be risk factors of thrombosis, independent of the type and site of the event, the presence of

Integrity signals

Registry

Crossref · 10.1182/blood-2002-11-3334

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266
Self-citation
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972
Self-citation
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 718
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 575
Self-citation
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
Oosting, J. D., Derksen, R. H. W. M., Bobbink, I. W. G., Hackeng, T. M., Bouma, B. N., & de Groot, P. G. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 487
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
Vaarala, O., Aho, K., Palosuo, T., Alfthan, G., Jauhiainen, M., & Leirisalo‐Repo, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91213-6 · Cited by 409
Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
Viard, J., Amoura, Z., & Bach, J. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90049-h · Cited by 266
β 2 -Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction
Brey, R. L., Abbott, R. D., Curb, J. D., Sharp, D. S., Ross, G. W., Stallworth, C. L., & Kittner, S. J. (2001) · Stroke · doi:10.1161/01.str.32.8.1701 · Cited by 250
Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus
Horbach, D. A., van Oort, E., Donders, R. C. J. M., Derksen, R. H. W. M., & de Groot, P. G. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650686 · Cited by 246
Heterogeneity in Meta-analysis of Data from Epidemiologic Studies: A Commentary
Colditz, G. A., Burdick, E., & Mosteller, F. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117644 · Cited by 245
Bias in meta-analytic research
Felson, D. T. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90072-u · Cited by 231
Anticardiolipin response in acute infections
Vaarala, O., Palosuo, T., Kleemola, M., & Aho, K. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90046-2 · Cited by 231
Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes, J., Cabral, A. R., & Alarcón-Segovia, D. (1995) · PubMed · Cited by 222
Development of an ELISA for Autoantibodies to Prothrombin Showing their Prevalence in Patients with Lupus Anticoagulants
Arvieux, J., Darnige, L., Caron, C., Reber, G., Bensa, J., & Colomb, M. G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649891 · Cited by 210
Antibodies to β2‐glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus
Tsutsumi, A., Matsuura, E., Ichikawa, K., Fujisaku, A., Mukai, M., Kobayashi, S., & Koike, T. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390905 · Cited by 192
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome
Amengual, O. (1996) · British journal of rheumatology · doi:10.1093/rheumatology/35.12.1239 · Cited by 192
Different Anticoagulant and Immunological Properties of Anti-Prothrombin Antibodies in Patients with Antiphospholipid Antibodies
Galli, M., Beretta, G., Daldossi, M., Bevers, E. M., & Barbui, T. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655994 · Cited by 168
Self-citation
Anti β2 glycoprotein I antibodies: detection and association with thrombosis
Martinuzzo, M. E., Forastiero, R. R., & Carreras, L. O. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03317.x · Cited by 163
Autoantibodies to Phospholipid-binding Plasma Proteins in Patients with Thrombosis and Phospholipid-reactive Antibodies
Pengo, V., Biasiolo, A., Brocco, T., Tonetto, S., & Ruffatti, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650355 · Cited by 159
Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?
Balestrieri, G., Tincani, A., Spatola, L., Allegri, F., Prati, E., Cattaneo, R., Valesini, G., Papa, N. D., & Meroni, P. L. (1995) · Lupus · doi:10.1177/096120339500400208 · Cited by 153
Antiprothrombin Antibodies: Detection and Clinical Significance in the Antiphospholipid Syndrome
Galli, M., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.7.2149.407a33_2149_2157 · Cited by 151
Self-citation
Antiprothrombin Antibodies: Detection and Clinical Significance in the Antiphospholipid Syndrome
Galli, M., & Barbui, T. (1999) · Blood · doi:10.1182/blood.v93.7.2149 · Cited by 147
Self-citation
Relationship of Anti β2-giycoprotein I and Anti Prothrombin Antibodies to Thrombosis and Pregnancy Loss in Patients with Antiphospholipid Antibodies
Forastiero, R. R., Martinuzzo, M. E., Cerrato, G. S., Kordich, L., & Carreras, L. O. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657678 · Cited by 146
Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
Matsuda, J., Saitoh, N., Gohchi, K., Gotoh, M., & Tsukamoto, A. M. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470112 · Cited by 137
Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complex
Sugi, T., & McIntyre, J. (1995) · Blood · doi:10.1182/blood.v86.8.3083.3083 · Cited by 133
Antibodies to Prothrombin Imply a Risk of Myocardial Infarction in Middle-Aged Men
Vaarala, O., Puurunen, M. K., Mänttäri, M., Manninen, V., Aho, K., & Palosuo, T. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650296 · Cited by 130
Antiphospholipid Syndrome: Diagnostic Aspects of Lupus Anticoagulants
Arnout, J. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616204 · Cited by 121
Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.
Reber, G., Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M., & Arvieux, J. (2002) · PubMed · Cited by 119
Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen- PE complex
Sugi, T., & McIntyre, J. (1995) · Blood · doi:10.1182/blood.v86.8.3083.bloodjournal8683083 · Cited by 119
Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day, H. M., Thiagarajan, P., Ahn, C. W., Reveille, J. D., Tinker, K. F., & Arnett, F. C. (1998) · PubMed · Cited by 96
Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
Cabral, A. R., Cabiedes, J., & Alarcón-Segovia, D. (1995) · PubMed · Cited by 95
The antiphospholipid syndrome II : autoimmune thrombosis
Asherson, R. A. (2002) · Cited by 91
Antibodies to β2-glycoprotein I—a specific marker for the antiphospholipid syndrome
Guerin, J., Feighery, C., Sim, R. B., & Jackson, J. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4601357.x · Cited by 91
Inter-laboratory Variability of Anti-β2-glycoprotein I Measurement
Schousboe, I., Tincani, A., Sanmarco, M., Kveder, T., de Moerloose, P., Boffa, M., Arvieux, J., & Reber, G. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613156 · Cited by 90
Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
Bertolaccini, M. L., Atsumi, T., Khamashta, M. A., Amengual, O., & Hughes, G. R. V. (1998) · PubMed · Cited by 89
Comparison of an enzyme‐linked immunosorbent assay for antibodies to β2‐glycoprotein I and a conventional anticardiolipin immunoassay
Roubey, R. A. S., Maldonado, M. A., & Byrd, S. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390922 · Cited by 86
Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus Erythematosus
Puurunen, M. K., Vaarala, O., Julkunen, H. A., Aho, K., & Palosuo, T. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0089 · Cited by 84
High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
Palosuo, T., Virtamo, J. R. K., Haukka, J. K., Taylor, P. R., Aho, K., Puurunen, M. K., & Vaarala, O. (1997) · PubMed · Cited by 77
Untitled work
(1998) · PubMed · Cited by 75
High Antibody Levels to Prothrombin Imply a Risk of Deep Venous Thrombosis and Pulmonary Embolism in Middle-aged Men
Palosuo, T., Virtamo, J. R. K., Haukka, J. K., Taylor, P. R., Aho, K., Puurunen, M. K., & Vaarala, O. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657711 · Cited by 71
Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadźba, J., Clerck, L. S. D., Stevens, W. J., Bridts, C. H., Cotthem, K. A. V., Musiał, J., Jankowski, M., & Szczeklik, A. (1997) · PubMed · Cited by 71
Prevalence and clinical significance of IgG isotype anti-β2-glycoprotein I antibodies in antiphospholipid syndrome: A comparative study w
Sanmarco, M., Soler, C., Christides, C., Raoult, D., Weiller, P. J., Gérolami, V., & Bernard, D. J. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90004-4 · Cited by 67
Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar.
Santiago, M., Martinelli, R. P., Ko, A. I., Reis, E. A., Fontes, R. D., Nascimento, E. G., Pierangeli, S. S., Espinola, R. G., & Gharavi, A. E. (2001) · PubMed · Cited by 60
Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
Lakos, G., Kiss, E. V., Regéczy, N., Tarján, P., Soltész, P., Zeher, M., Bodolay, E., Szűcs, G., Szakony, S., Sipka, S., et al. (2000) · PubMed · Cited by 60
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz, F. J., Reverter, J. C., Font, J., Tàssies, D., Cervera, R., Espinosa, G., Carmona, F., Balasch, J., Ordinas, A., & Ingelmo, M. (2000) · PubMed · Cited by 56
Anti‐prothrombin antibodies combined with lupus anti‐coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus
Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y., & Kanakura, Y. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02950.x · Cited by 54
Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce, I. N., Clark-Soloninka, C. A., Spitzer, K. A., Gladman, D. D., Urowitz, M. B., & Laskin, C. A. (2000) · PubMed · Cited by 52
Antibodies to Factor XII Associated with Lupus Anticoagulant
Gallimore, M. J., Harris, S. L., Winter, M., & Jones, D. W. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614483 · Cited by 51
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia
Giordano, P., Galli, M., Vecchio, G., Altomare, M., Norbis, F., Ruggeri, L., Petronelli, M., & Mattia, D. D. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00853.x · Cited by 51
Self-citation
Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome
Bidot, C., Jy, W., Horstman, L. L., Huisheng, H., Jimenez, J. J., Yaniz, M., & Ahn, Y. S. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04161.x · Cited by 51
Lupus Anticoagulants and Thrombosis: Clinical Association of Different Coagulation and Immunologic Tests
Dlott, J., Norbis, F., Ruggeri, L., Cler, L., Triplett, D., Barbui, T., & Galli, M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614164 · Cited by 48
Self-citation
Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
Lee, S., Cho, M. L., Joo, Y.-S., Kim, W. U., Hong, Y. S., Min, J., Lee, S. H., Park, S. H., Cho, C. S., & Kim, H. (2001) · PubMed · Cited by 41
Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
Martinuzzo, M. E., Pombo, G., Forastiero, R. R., Cerrato, G. S., Colorio, C. C., & Carreras, L. (1998) · PubMed · Cited by 39
Antibodies to tissue‐type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
Cugno, M., Domínguez, M., Cabibbe, M., Bisiani, G., Galli, M., Anglés‐Cano, E., & Agostoni, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01948.x · Cited by 39
Self-citation
Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism
Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P., & Girolami, A. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00105-x · Cited by 38
Anti‐prothrombin antibodies: assay conditions and clinical associations in the anti‐phospholipid syndrome
Donohoe, S., Mackie, I. J., Isenberg, D. A., & Machin, S. J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02716.x · Cited by 38
Some Patients with Antiphospholipid Syndrome Express hitherto Undescribed Antibodies to Cardiolipin-binding Proteins
Rampazzo, P., Biasiolo, A., Garin, J., Rosato, A., Betterle, C., Ruffatti, A., & Pengo, V. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612904 · Cited by 34
A Cross Sectional Study of Antiphospholipid-protein Antibodies in Patients with Venous Thromboembolism
Amiral, J., Martin, L. D. S., Mottier, D., & Pasquier, É. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616083 · Cited by 25
Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome.
Sorice, M., Pittoni, V., Circella, A., Misasi, R., Conti, F., Longo, A., Pontieri, G. M., & Valesini, G. (1998) · PubMed · Cited by 25
The Antiphospholipid Syndrome II
Bijl, M., & Kallenberg, C. G. M. (2002) · Elsevier eBooks · doi:10.1016/b978-0-444-50987-1.x5000-1 · Cited by 23
Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies in Antiphospholipid-Negative Patients with Thrombosis
Previtali, S., Barbui, T., & Galli, M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613293 · Cited by 19
Self-citation
Is there a Role for Anti-phospholipid-binding Protein Antibodies in the Pathogenesis of Thrombosis in Behcet’s Disease?
Priori, R., Conti, F., Pittoni, V., Garofalo, T., Sorice, M., & Valesini, G. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613776 · Cited by 13
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
Oosting, J., Derksen, R. H. W. M., Bobbink, I., et al. (1993) · Blood · doi:10.1182/blood.v81.10.2618.bloodjournal81102618 · Cited by 12
Antibodies to Cardiolipin and other Phospholipids
Pierangeli, S. S., & Harris, E. N. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50006-1 · Cited by 3
β2-glycoprotein-I and Anti-β2-glycoprotein-I Antibodies
de Groot, P. G., Bouma, B., Lutters, B. C. H., & Derksen, R. H. W. M. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50007-3 · Cited by 3
Untitled work
Wilson (1999) · doi:10.1002/1529-0131(199907)42:7
Untitled work
Atsumi (2000) · doi:10.1002/1529-0131(200009)43:9

Research works printed but not linked: 2

Galli M, Bevers EM, Barbui T. Immunologic properties and anticoagulant activity of antiphospholipid antibodies. In: Levine SR, Brey RL, eds. Clinical Approach to Antiphospolipid Antibodies. Boston, MA: Butterworth; 2000: 19-31.
Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost.1995;74: 1120-1125. · DOI

Sorted by citations

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Guidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740

See all 413

Authors: Galli, M., Luciani, D., Bertolini, G., & Barbui, T.
Affiliations: From the Division of Hematology, Ospedali Riuniti, Bergamo, Italy; and the Laboratory of Clinical Epidemiology, Istituto “Mario Negri,” Ranica Bergamo (BG), Italy.
ORCID: Galli, Monica
Luciani, Davide
Bertolini, Guido
Barbui, Tiziano
Venue: Blood
Publisher: American Society of Hematology
Published: 2003-10-15
Volume: 102
Issue: 8
Pages: 2717-2723
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2002-11-3334
OpenAlex: W2069794594
Cited by: 413
References: 72
Citations by year: 2026: 4 · 2025: 4 · 2024: 8 · 2023: 9 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 11 · 2017: 13 · 2016: 16 · 2015: 20 · 2014: 17 · 2013: 27 · 2012: 26
FWCI: 4.16
Type: journal article
Language: en
Open access: closed
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords: antiphospholipid syndrome, anti-beta2-glycoprotein I antibodies, anti-prothrombin antibodies, lupus anticoagulant, thrombosis risk, thrombosis risk factors, pregnancy complications
MeSH terms: Antibodies, Cardiolipins, Female, Glycoproteins, Humans, Pregnancy, Pregnancy Complications, Hematologic, Prothrombin, Retrospective Studies, Thrombosis, Odds Ratio, Antiphospholipid Syndrome, beta 2-Glycoprotein I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks